Senior insider sale
President, R&D & CMO at MAZE THERAPEUTICS, INC. — senior position signals high conviction
$7.10M
164.85K shares
What this filing means
BERNSTEIN HAROLD plans to sell 164.85K shares of MAZE THERAPEUTICS, INC. valued at approximately $7.10M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/10/2026ACC: 0001950047-26-002427
Officer· President, R&D & CMO
Since Mar 2026
164.85K
Shares to sell
$7.10M
Approx. market value
74.85K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
3/10/2026
74.85KTotal acquired74.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/10/2026 | Exercise of Stock Options Cash | 74.85K | — |
| Total | 74.85K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
15K
Market value
$690.3K
2/2/2026
—Completed
Units to sell
25.16K
Market value
$1.01M
1/7/2026
—Completed
Units to sell
412.00
Market value
$16.5K
1/5/2026
—Completed
Units to sell
4.43K
Market value
$179.2K
1/2/2026
—Completed
Units to sell
45K
Market value
$1.83M
12/29/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
74.85K
Market value
$3.37M
3/10/2026
Total
Units
164.85K
Value
$7.10M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/2/2026 | 15K | $690.3K | — | Completed |
1/7/2026 | 25.16K | $1.01M | — | Completed |
1/5/2026 | 412.00 | $16.5K | — | Completed |
1/2/2026 | 4.43K | $179.2K | — | Completed |
12/29/2025 | 45K | $1.83M | — | Completed |
| Planned — Approximate Date | ||||
3/10/2026 | 74.85K | $3.37M | NASDAQ | Planned |
| Total | 164.85K | $7.10M | ||